CAPR

Capricor Therapeutics, Inc. is a leading biotechnology company headquartered in Beverly Hills, California, dedicated to pioneering cell- and exosome-based therapies for the treatment and prevention of a range of diseases. Emphasizing regenerative medicine, Capricor leverages its proprietary technologies to develop innovative solutions that significantly address unmet medical needs. With a robust R&D pipeline, the company is positioned to make a transformative impact on patient outcomes, underscoring its commitment to advancing healthcare through scientific excellence and strategic partnerships in the biopharmaceutical industry.